Statin Add-On Therapy for Hypercholesterolemia
The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.
Important Considerations When Prescribing Statin Therapy for Hypercholesterolemia
What to know about the efficacy of statin therapies used as cholesterol-lowering therapy.
Strategies Used to Treat Hypercholesterolemia
The standard of care for managing high cholesterol levels.
Multidisciplinary Approaches to Reducing CVD Risk
The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.
Case Study: Reducing Renal Progression With SGLT-2 Inhibitors
October 29th 2021A case study for a patient who required additional SGLT-2 inhibitors to help reduce progression of renal disease is presented, and Drs Robert Busch, Dhiren Patel, and Muthiah Vadugananthan share their final thoughts on renal protective agents.
Risks and Complications for Chronic Kidney Disease
October 29th 2021An expert endocrinologist and cardiologist discuss the risks and complications of renal disease associated with diabetes and cardiovascular disease. Dr Robert Busch also provides an overview of some of the studies done in renal impairment.
Case Study: Insulin Pump for Patient With T2DM
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, presents a case study of a patient with type 2 diabetes mellitus, an insulin pump, and a continuous glucose monitor.
Impact of Technology on Diabetes and Quality of Life
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into quality-of-life improvements that have followed advances in diabetes technology and review available continuous glucose monitors.
Improved Metrics for Evaluating Glucose Control in Diabetes
Robert Busch, MD, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discuss metrics to evaluate diabetes control, including time in range and coefficient of variation.
Continuous Glucose Monitors in Type 1 and Type 2 Diabetes
A panel of experts discuss the impact of continuous glucose monitoring (CGM) on individualized patient care plans for patients with type 1 and type 2 diabetes.
Robert Busch, MD, and Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into the use of insulin pumps in type 2 diabetes and describe currently available smart pumps.
Role of Technology in Diabetes Care
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide an overview of the pillars of technology utilized in diabetes care: Continuous glucose monitors (CGMs), smart insulin pumps, and connected insulin pens.